ClinicalTrials.gg
CompletedNCT01925677Updated Nov 20, 2019Results posted

Robotic Single Port Donor Nephrectomy

An interventional study of da Vinci® Single-Site™ in Renal Transplant Donor of Left Kidney, Donor Nephrectomy and Robotic Surgery, sponsored by University of Maryland, Baltimore. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-11-20.

Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Feasibility study on robotic-assisted single-site donor nephrectomy utilizing da Vinci instrumentation and Single-Site platforms.

Read the detailed description

Our center has performed over 200 single-port donor nephrectomies with standard laparoscopy and has reported patient benefits associated with a single port approach. The single port robotic platform offers the potential to ameliorate the significant technical and ergonomic challenges that currently limit more widespread application of single port donor surgery. After being informed of the potential risks and off-label use of the da Vinci Single-Site approach in our study, patients will undergo a robotic-assisted single-site donor nephrectomy performed by a two-surgeon team utilizing existing da Vinci instrumentation and Single-Site platforms. Renal mobilization and vascular dissection will be performed with manual laparoscopy performed for vascular division utilizing stapling devices.

02

Conditions studied

  • Renal Transplant Donor of Left Kidney
  • Donor Nephrectomy
  • Robotic Surgery
  • Single-port

Keywords

  • Transplant
  • donor
  • nephrectomy
  • robotic
  • laparoscopy
  • single-port
03

In context

Lead sponsor

University of Maryland, Baltimore is the lead sponsor of 696 studies on the registry; 131 are open to participants now.

Of its 91 completed or terminated interventional studies of FDA-regulated products, 63 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient must be approved by the Living Donor Center.
  • Patient must have compatible blood type with the recipient.
  • Patient must have body mass index less than 35.
  • Patient must have appropriate anatomy for left kidney donation.

Exclusion criteria

Exclusion Criteria:

  • Any patient receiving anticoagulant drugs such as Coumadin or warfin
  • Any patient suffering from an active urinary tract infections
  • Any patients suffering from cancer.
  • Any patients suffering from diabetes.
  • Any patients suffering from kidney disease.
  • Any patients suffering from heart disease.
  • Any patients suffering from liver disease.
  • Any patients suffering from HIV or hepatitis
  • Any patients suffering from previous major abdominal surgery.
  • Any patients suffering from more than two left renal arteries.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    da Vinci® Single-Site™

    Robotic-assisted single-incision laparoscopic nephrectomy.

    Device: da Vinci® Single-Site™

Interventions

  • Deviceda Vinci® Single-Site™

    Planned single-incision laparoscopic nephrectomy performed with the assistance of the Da Vinci Robotic Surgical System.

06

What researchers measure

Primary outcomes

  1. Successful Completion of the Surgical Procedure

    The primary objective is to determine the feasibility measure of the current Single-Site platform to perform donor nephrectomy prior to vascular division and extraction. Specifically, it will be recorded which portions of the operation utilized the robotic device. The primary outcome variable is the completion of the operation for kidney donation.

    Time frame: during operation

Secondary outcomes

  1. Operative Times

    Operative times will closely be measured

    Time frame: during operation

  2. Blood Loss

    Blood loss of patients will be closely monitored and recorded.

    Time frame: during operation

  3. The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.

    A surgeon ergonomics questionnaire will be given to surgeons after performing both robotic assisted and standard laparoscopic single port donor nephrectomies. The results from both of these surveys will then be compared. These are qualitative and were not analyzed for statistical trends.

    Time frame: intra-operative experience collected within 24 hours

07

Results

Posted Nov 20, 2019

Participant flow

Participant flow — Overall Study
Milestoneda Vinci® Single-Site™
Started3
Completed3
Not completed0

Outcome measures

PrimarySuccessful Completion of the Surgical Procedure

The primary objective is to determine the feasibility measure of the current Single-Site platform to perform donor nephrectomy prior to vascular division and extraction. Specifically, it will be recorded which portions of the operation utilized the robotic device. The primary outcome variable is the completion of the operation for kidney donation.

Time frame:
during operation
Reported as:
Count of participants · Participants
Successful Completion of the Surgical Procedure
Participantsda Vinci® Single-Site™
Successful Completion of the Surgical Procedure3
SecondaryOperative Times

Operative times will closely be measured

Time frame:
during operation
Reported as:
Mean · minutes
Operative Times
minutesda Vinci® Single-Site™
Operative Times82 ± 16
SecondaryBlood Loss

Blood loss of patients will be closely monitored and recorded.

Time frame:
during operation
Reported as:
Mean · mL
Blood Loss
mLda Vinci® Single-Site™
Blood Loss77 ± 64
SecondaryThe Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.

A surgeon ergonomics questionnaire will be given to surgeons after performing both robotic assisted and standard laparoscopic single port donor nephrectomies. The results from both of these surveys will then be compared. These are qualitative and were not analyzed for statistical trends.

Time frame:
intra-operative experience collected within 24 hours
Reported as:
Number · participants
The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.
participantsda Vinci® Single-Site™
The Comparison of Surgeon Ergonomic Questionnaires in Robotic Assisted Versus Standard Laparoscopic Single Port Donor Nephrectomies.3

Adverse events

Collected over Data was collected for 1 year from time of surgery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
da Vinci® Single-Site™0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)da Vinci® Single-Site™
<=18 years0
Between 18 and 65 years3
>=65 years0
Age, Continuous
Age, Continuous(years)da Vinci® Single-Site™
Median52 (42 to 58)
Sex: Female, Male
Sex: Female, Male(Participants)da Vinci® Single-Site™
Female3
Male0
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)da Vinci® Single-Site™
Race Caucasian3
Region of Enrollment
Region of Enrollment(participants)da Vinci® Single-Site™
United States3
Number of participants
Number of participants(Participants)da Vinci® Single-Site™
Count of participants3
08

Study locations

1 site
  • University of Maryland Medical Center
    Baltimore, Maryland 21201, United States
09

References and documents

Publications

  • Barth RN, Phelan MW, Goldschen L, Munivenkatappa RB, Jacobs SC, Bartlett ST, Philosophe B. Single-port donor nephrectomy provides improved patient satisfaction and equivalent outcomes. Ann Surg. 2013 Mar;257(3):527-33. doi: 10.1097/SLA.0b013e318262ddd6. PubMed 22968070 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 5, 2013

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01925677
Responsible party
Rolf Barth (Director of Liver Transplantation, University of Maryland, Baltimore) — Principal investigator
First posted
Aug 20, 2013
Start date
Jan 2015
Primary completion
Aug 2017
Completion
Aug 2017
Results posted
Nov 20, 2019
Last update
Nov 20, 2019

Study contacts

Rolf N Barth, M.D.
principal investigator · University of Maryland, Baltimore

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion